In pursuit of the above objective, leucine-rich α-2 glycoprotein 1 (LRG1) has been identified over the preceding decade as a vasculopathic factor that contributes to the pathogenesis of a variety of diseases including cancer, nvAMD, DR and kidney disease [23–30]. The gene discussed is LRG1; the disease is cancer.